152 related articles for article (PubMed ID: 2908642)
1. Immunotoxins for ex vivo bone marrow purging in human bone marrow transplantation.
Vallera DA
Cancer Treat Res; 1988; 37():515-35. PubMed ID: 2908642
[No Abstract] [Full Text] [Related]
2. Autologous bone marrow transplantation in acute leukemia and lymphoma following ex vivo treatment with monoclonal antibodies and complement.
Freedman AS; Takvorian T; Nadler LM; Anderson KC; Sallan SE; Ritz J
Cancer Treat Res; 1988; 38():265-83. PubMed ID: 2908599
[No Abstract] [Full Text] [Related]
3. T cell depletion in allogenic bone marrow transplantation. Progress and problems.
Marmont AM
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():229-32. PubMed ID: 2653509
[No Abstract] [Full Text] [Related]
4. Allograft and autograft purging using immunotoxins in clinical bone marrow transplantation for hematologic malignancies.
Uckun FM; Myers DE
J Hematother; 1993; 2(2):155-63. PubMed ID: 7921971
[TBL] [Abstract][Full Text] [Related]
5. Prevention of graft-versus-host disease by using immunotoxins.
Laurent G; Bouloux C
Prog Clin Biol Res; 1992; 377():129-36; discussion 137. PubMed ID: 1438408
[No Abstract] [Full Text] [Related]
6. Cure after allogeneic bone marrow transplantation: chemo-radiotherapy and/or graft-versus-leukemia?
Hagenbeek A; Martens AC; Schultz FW; van Bekkum DW
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():91-3. PubMed ID: 2390645
[No Abstract] [Full Text] [Related]
7. Graft-versus-host disease prevention in allogeneic bone marrow transplantation from histocompatible siblings. A pilot study using immunotoxins for T cell depletion of donor bone marrow.
Filipovich AH; Vallera DA; Youle RJ; Haake R; Blazar BR; Arthur D; Neville DM; Ramsay NK; McGlave P; Kersey JH
Transplantation; 1987 Jul; 44(1):62-9. PubMed ID: 3299923
[TBL] [Abstract][Full Text] [Related]
8. XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.
Koehler M; Hurwitz CA; Krance RA; Coustan-Smith E; Williams LL; Santana V; Ribeiro RC; Brenner MK; Heslop HE
Bone Marrow Transplant; 1994 May; 13(5):571-5. PubMed ID: 7519937
[TBL] [Abstract][Full Text] [Related]
9. T-cell depletion and allogeneic bone marrow transplantation.
O'Reilly RJ
Semin Hematol; 1992 Apr; 29(2 Suppl 1):20-6. PubMed ID: 1615341
[No Abstract] [Full Text] [Related]
10. Purging by dye-mediated photosensitization.
Porcellini A; Manna M; Marchetti-Rossi MT; Sparaventi G
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():188-9. PubMed ID: 2653501
[No Abstract] [Full Text] [Related]
11. Mixed chimerism after allogeneic marrow transplantation.
Frassoni F; Corvo R; Strada P; Sessarego M; Piaggio G; Figari O; Scarpati D; Bacigalupo A; Vitale V; Miceli S
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():241-3. PubMed ID: 2653512
[No Abstract] [Full Text] [Related]
12. Pharmacological bone marrow purging with drugs other than cyclophosphamide derivatives.
Douay L
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():195. PubMed ID: 2469509
[No Abstract] [Full Text] [Related]
13. Perspectives of monoclonal antibodies in the acute leukaemias.
Hervé P; Wijdenes J; Racadot E
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():198-201. PubMed ID: 2653503
[No Abstract] [Full Text] [Related]
14. T-cell depletion in allogeneic bone marrow transplantation for acute leukaemias.
Aversa F; Terenzi A; Carotti A; Velardi A; Latini P; Gambelunghe C; Grignani F; Martelli MF
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():69-72. PubMed ID: 2697440
[No Abstract] [Full Text] [Related]
15. Depletion of bone marrow T-lymphocytes with an anti-CD5 monoclonal immunotoxin (ST-1 immunotoxin): effective prophylaxis for graft-versus-host disease.
Antin JH; Bierer BE; Smith BR; Guinan EC; Provost MM; Ferrara J; Macklis RM; Tarbell NJ; Blythman H; Bouloux C
Prog Clin Biol Res; 1990; 333():207-15. PubMed ID: 1689852
[No Abstract] [Full Text] [Related]
16. T-cell depletion for bone marrow transplantation: effects on graft rejection, graft-versus-host disease, graft-versus-leukemia, and survival.
Champlin RE
Cancer Treat Res; 1990; 50():99-111. PubMed ID: 1976361
[TBL] [Abstract][Full Text] [Related]
17. [Autotransplantation in acute leukemia].
Rizzoli V; Mangoni L; Carlo-Stella C; Bonati A
Haematologica; 1989 Oct; 74(5 Suppl):24-48. PubMed ID: 2512210
[No Abstract] [Full Text] [Related]
18. T-cell depletion in unrelated bone marrow transplantation.
Tricot G
Semin Hematol; 1992 Apr; 29(2 Suppl 1):26-31; discussion 31-2. PubMed ID: 1615342
[No Abstract] [Full Text] [Related]
19. Graft-versus-leukemia without graft-versus-host disease: an elusive goal of bone marrow transplantation.
Champlin R
Semin Hematol; 1992 Jul; 29(3 Suppl 2):46-52. PubMed ID: 1509294
[No Abstract] [Full Text] [Related]
20. Immunomagnetic depletion of CD8+ lymphocytes from marrow grafts.
Jansen J; Hanks S; English D; Karaffa R; Akard L
Prog Clin Biol Res; 1992; 377():405-10. PubMed ID: 1438437
[No Abstract] [Full Text] [Related]
[Next] [New Search]
